CLINICAL TRIALS PROFILE FOR IRSOGLADINE
✉ Email this page to a colleague
Clinical Trials for Irsogladine
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT02581696 ↗ | The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers | Completed | The Catholic University of Korea | Phase 1 | An open-label, multiple-dose, single-arm, phase 1 study to evaluate the drug-drug interaction and safety of Lafutidine and Irsogladine maleate in healthy adult volunteers |
NCT02581696 ↗ | The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers | Completed | Boryung Pharmaceutical Co., Ltd | Phase 1 | An open-label, multiple-dose, single-arm, phase 1 study to evaluate the drug-drug interaction and safety of Lafutidine and Irsogladine maleate in healthy adult volunteers |
NCT02759224 ↗ | A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet | Completed | Boryung Pharmaceutical Co., Ltd | Phase 1 | An Open-Label, Randomized, Single-dose, 2x2 Crossover Study to Compare the Pharmacokinetics of BRI-1501 Tablet and Coadministration of Lafutidine and Irsogladine maleate as Individual Tablets in Healthy Adult Volunteers |
NCT03509831 ↗ | [KJ-INT-002] BE Study | Unknown status | Kukje Pharma | Phase 1 | Assess the Safety and the Pharmacokinetic Characteristics of INT-2150 after Oral Administration to Healthy Adult Male Subjects |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Irsogladine
Condition Name
Clinical Trial Locations for Irsogladine
Clinical Trial Progress for Irsogladine
Clinical Trial Phase
Clinical Trial Sponsors for Irsogladine
Sponsor Name